U87

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 9274656 Experts worldwide ranked by ideXlab platform

Jean Michel Pouvesle - One of the best experts on this subject based on the ideXlab platform.

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of an in vivo plasma treatment on a U87-luc glioma tumor. A pulsed DBD with µs pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that the plasma treatment was safe for mice. However, the reiterated long time plasma treatment (20 min, 3 consecutive days) produces a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatical U87 bioluminescence decrease associated with a reduction of tumor volume in U87 glioma-bearing mice

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of in vivo plasma treatment on U87-luc glioma tumor. A pulsed DBD with ms pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that plasma treatment was safe for mice. However reiterated long time plasma treatment (20 min, 3 consecutive days) produce a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatically U87 bioluminescence decrease associated to a reduction of tumor volume in U87 glioma-bearing mice.

Marc Vandamme - One of the best experts on this subject based on the ideXlab platform.

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of an in vivo plasma treatment on a U87-luc glioma tumor. A pulsed DBD with µs pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that the plasma treatment was safe for mice. However, the reiterated long time plasma treatment (20 min, 3 consecutive days) produces a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatical U87 bioluminescence decrease associated with a reduction of tumor volume in U87 glioma-bearing mice

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of in vivo plasma treatment on U87-luc glioma tumor. A pulsed DBD with ms pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that plasma treatment was safe for mice. However reiterated long time plasma treatment (20 min, 3 consecutive days) produce a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatically U87 bioluminescence decrease associated to a reduction of tumor volume in U87 glioma-bearing mice.

Alain Le Pape - One of the best experts on this subject based on the ideXlab platform.

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of an in vivo plasma treatment on a U87-luc glioma tumor. A pulsed DBD with µs pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that the plasma treatment was safe for mice. However, the reiterated long time plasma treatment (20 min, 3 consecutive days) produces a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatical U87 bioluminescence decrease associated with a reduction of tumor volume in U87 glioma-bearing mice

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of in vivo plasma treatment on U87-luc glioma tumor. A pulsed DBD with ms pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that plasma treatment was safe for mice. However reiterated long time plasma treatment (20 min, 3 consecutive days) produce a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatically U87 bioluminescence decrease associated to a reduction of tumor volume in U87 glioma-bearing mice.

Julien Sobilo - One of the best experts on this subject based on the ideXlab platform.

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of an in vivo plasma treatment on a U87-luc glioma tumor. A pulsed DBD with µs pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that the plasma treatment was safe for mice. However, the reiterated long time plasma treatment (20 min, 3 consecutive days) produces a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatical U87 bioluminescence decrease associated with a reduction of tumor volume in U87 glioma-bearing mice

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of in vivo plasma treatment on U87-luc glioma tumor. A pulsed DBD with ms pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that plasma treatment was safe for mice. However reiterated long time plasma treatment (20 min, 3 consecutive days) produce a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatically U87 bioluminescence decrease associated to a reduction of tumor volume in U87 glioma-bearing mice.

Sébastien Dozias - One of the best experts on this subject based on the ideXlab platform.

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of an in vivo plasma treatment on a U87-luc glioma tumor. A pulsed DBD with µs pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that the plasma treatment was safe for mice. However, the reiterated long time plasma treatment (20 min, 3 consecutive days) produces a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatical U87 bioluminescence decrease associated with a reduction of tumor volume in U87 glioma-bearing mice

  • Antitumor Effect of Plasma Treatment on U87 Glioma Xenografts: Preliminary Results
    Plasma Processes and Polymers, 2010
    Co-Authors: Marc Vandamme, Eric Robert, Sabrina Pesnel, Emerson Barbosa, Sébastien Dozias, Julien Sobilo, Stéphanie Lerondel, Alain Le Pape, Jean Michel Pouvesle
    Abstract:

    This work was conducted to evaluate the potential antitumor effect of in vivo plasma treatment on U87-luc glioma tumor. A pulsed DBD with ms pulses at moderate power was used for treatment. Electrical analyses and spectroscopic measurements were realized to characterize plasma properties. We showed that plasma treatment was safe for mice. However reiterated long time plasma treatment (20 min, 3 consecutive days) produce a superficial burn. During plasma treatment, we observed an increase of subcutaneous temperature and a cutaneous skin pH reduction. After 5 d of plasma treatment, we observed a dramatically U87 bioluminescence decrease associated to a reduction of tumor volume in U87 glioma-bearing mice.